Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Ernesto Sparrelid to Cholangiocarcinoma

This is a "connection" page, showing publications Ernesto Sparrelid has written about Cholangiocarcinoma.

 
Connection Strength
 
 
 
3.668
 
  1. Jansson H, Villard C, Nooijen LE, Ghorbani P, Erdmann JI, Sparrelid E. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2023 04; 49(4):688-699.
    View in: PubMed
    Score: 0.780
  2. Jansson H, Sparrelid E. Letter to the Editor: The Role of Surgery in Multiple Intrahepatic Cholangiocarcinoma Should Not Be Dismissed Without Further Analysis. Hepatology. 2021 10; 74(4):2318-2319.
    View in: PubMed
    Score: 0.708
  3. Jansson H, Cornillet M, Bj?rkstr?m NK, Sturesson C, Sparrelid E. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort. Eur J Surg Oncol. 2020 05; 46(5):804-810.
    View in: PubMed
    Score: 0.629
  4. Olthof PB, Bouwense SAW, Bednarsch J, Dewulf M, Kazemier G, Maithel S, Jarnagin WR, Aldrighetti L, Roberts KJ, Troisi RI, Malago MM, Lang H, Alikhanov R, Ruzzenente A, Malik H, Charco R, Sparrelid E, Pratschke J, Cescon M, Nadalin S, Hagendoorn J, Schadde E, Hoogwater FJH, Schnitzbauer AA, Topal B, Lodge P, Olde Damink SWM, Neumann UP, Groot Koerkamp B. Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort. Ann Surg Oncol. 2025 Mar; 32(3):1762-1768.
    View in: PubMed
    Score: 0.220
  5. Villard C, Widman L, Sparrelid E, Bergquist A, Hagstr?m H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
    View in: PubMed
    Score: 0.220
  6. Ratti F, Marino R, Olthof PB, Pratschke J, Erdmann JI, Neumann UP, Prasad R, Jarnagin WR, Schnitzbauer AA, Cescon M, Guglielmi A, Lang H, Nadalin S, Topal B, Maithel SK, Hoogwater FJH, Alikhanov R, Troisi R, Sparrelid E, Roberts KJ, Malag? M, Hagendoorn J, Malik HZ, Olde Damink SWM, Kazemier G, Schadde E, Charco R, de Reuver PR, Groot Koerkamp B, Aldrighetti L. Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation. Hepatology. 2024 02 01; 79(2):341-354.
    View in: PubMed
    Score: 0.202
  7. Zimmer CL, Filipovic I, Cornillet M, O'Rourke CJ, Berglin L, Jansson H, Sun D, Strauss O, Hertwig L, Johansson H, von Seth E, Sparrelid E, Dias J, Glaumann H, Melum E, Ellis EC, Sandberg JK, Andersen JB, Bergquist A, Bj?rkstr?m NK. Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma. Hepatology. 2022 05; 75(5):1154-1168.
    View in: PubMed
    Score: 0.181
  8. D'Souza MA, Al-Saffar HA, Fern?ndez Moro C, Shtembari S, Danielsson O, Sparrelid E, Sturesson C. Redefining resection margins and dissection planes in perihilar cholangiocarcinoma-radical resection is a rare event. Virchows Arch. 2022 Mar; 480(3):557-564.
    View in: PubMed
    Score: 0.180
  9. Ruzzenente A, Bagante F, Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Koerkamp BG, Jarnagin WR, Nadalin S, Pratschke J, Schmelzle M, Sparrelid E, Lang H, Iacono C, van Gulik TM, Guglielmi A. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group. Ann Surg Oncol. 2021 Nov; 28(12):7719-7729.
    View in: PubMed
    Score: 0.173
  10. Jansson H, Olthof PB, Bergquist A, Ligthart MAP, Nadalin S, Troisi RI, Groot Koerkamp B, Alikhanov R, Lang H, Guglielmi A, Cescon M, Jarnagin WR, Aldrighetti L, van Gulik TM, Sparrelid E. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study. HPB (Oxford). 2021 11; 23(11):1751-1758.
    View in: PubMed
    Score: 0.173
  11. R?sok BI, Bj?rnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bj?rnbeth BA, Isaksson B, Sandstr?m P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
    View in: PubMed
    Score: 0.119
  12. Uijterwijk BA, Lemmers DH, Fusai GK, Zerbi A, Salvia R, Sparrelid E, White S, Bj?rnsson B, Mavroeidis VK, Roberts KJ, Mazzola M, Cab?s SS, Soonawalla Z, Korkolis D, Serradilla M, Pessaux P, Luyer M, Mowbray N, Ielpo B, Mazzotta A, Kleeff J, Boggi U, Mu?oz MAS, Goh BKP, Andreotti E, Wilmink H, Ghidini M, Zaniboni A, Verbeke C, Adsay V, Bianchi D, Besselink MG, Abu Hilal M. Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review. Ann Surg Oncol. 2024 Jul; 31(7):4654-4664.
    View in: PubMed
    Score: 0.053
  13. Bj?rnsson B, Sparrelid E, Hasselgren K, Gasslander T, Isaksson B, Sandstr?m P. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases. Scand J Surg. 2016 Sep; 105(3):158-62.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)